Plasma phospho-tau181 increases with Alzheimer’s disease clinical severity and is associated with tau-PET and amyloid-PET

INTRODUCTION: We examined and compared plasma phospho-tau181 (pTau181) and total tau: 1) across the Alzheimer’s disease (AD) clinical spectrum; 2) in relation to brain amyloid (Aβ) PET, tau PET, and cortical thickness; and 3) as a screening tool for elevated brain Aβ. METHODS: Participants included...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Dement
Main Authors: Mielke, Michelle M., Hagen, Clinton E., Xu, Jing, Chai, Xiyun, Vemuri, Prashanthi, Lowe, Val J., Airey, David C., Knopman, David S., Roberts, Rosebud O., Machulda, Mary M., Jack, Clifford R., Petersen, Ronald C., Dage, Jeffrey L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6097897/
https://ncbi.nlm.nih.gov/pubmed/29626426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2018.02.013
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados